Studying Drug-DNA Interactions
Once we have a single DNA molecule, we can flow the small molecules (prospective drugs for cancer/HIV), then stretch and relax the DNA in the presence of the molecules. This allows us to quantify the binding properties and identify the binding mechanism of the potential drug of interest.
Current Projects and Project Leaders
Binuclear Ruthenium Threading Complexes: Adam Jabak & Nicholas Bryden
Doxorubicin: Zachary Ells & Brian Dolle
Nogalamycin: Noah Whitney
Polymerase Kappa: Josh Watts